Ecuador’s market regulator, the Superintendence for the Control of Market Power (SCPM) has said it detected some irregularities in a recent reverse-auction bidding for supplying medication to the country’s health system. The agency will look into alleged anti-competitive practices, and has said it expects to find evidence of crimes against the State.
“I have in my hands a statement by the Company Superintendence, dealing with their impressions on the Limerickpharma, Ginsberg and Sionpharm case. But let me tell you, this isn’t the only concern” said SCPM’s head, Pedro Páez.
Ecuador’s Public Contract Service (Sercop) has revealed that 416 medications were included in the reverse auction, starting at a cost of $220 million USD. The winners, a joint bid by the three companies above, walked away with the contract for $34.8 million USD. However, all three companies operate out of the same building, raising initial suspicions, as they share an address. Furthermore, Sionpharm and Ginsberg both have the same General Manager registered before the country’s Company registry – a Mr. Marco Serrano. These details were enough to prompt the agency into taking action.
Full Content: El Comercio
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI